Larry W. Kwak

Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by β-Defensin 2

Arya Biragyn, Pier Adelchi Ruffini, Cynthia A. Leifer et al. · Science · 2002 · 885 citations

Microbial Pathogens, Innate Immune System, Immunology +19

Complete molecular remissions induced by patient-specific vaccination plus granulocyte–monocyte colony-stimulating factor against lymphoma

Maurizio Bendandi, Christopher D. Gocke, Carol B. Kobrin et al. · Nature Medicine · 1999 · 591 citations

Vaccination, Lymphoid Neoplasia, Tumor Immunology +12

Induction of Immune Responses in Patients with B-Cell Lymphoma against the Surface-Immunoglobulin Idiotype Expressed by Their Tumors

Larry W. Kwak, Michael J. Campbell, Debra K. Czerwinski et al. · New England Journal of Medicine · 1992 · 544 citations

Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial

Jason R. Westin, Fuliang Chu, Min Zhang et al. · The Lancet Oncology · 2013 · 528 citations · Full text

Lymphoid Neoplasia, Medicine, Immunology +10

Tumor-Specific Idiotype Vaccines in the Treatment of Patients With B-Cell Lymphoma — Long-Term Results of a Clinical Trial

Frank J. Hsu, Clemens B. Caspar, Debra K. Czerwinski et al. · Blood · 1997 · 453 citations · Full text